Inhibition of colonic aberrant crypt formation by the dietary flavonoids (+)-catechin and hesperidin

Adv Exp Med Biol. 2002;505:123-33. doi: 10.1007/978-1-4757-5235-9_11.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Anticarcinogenic Agents / pharmacology*
  • Anticarcinogenic Agents / therapeutic use
  • Beverages / analysis
  • Carcinogens / toxicity
  • Catechin / pharmacology*
  • Catechin / therapeutic use
  • Cell Transformation, Neoplastic / drug effects*
  • Citrus / chemistry
  • Colon / drug effects*
  • Colon / pathology
  • Colonic Neoplasms / chemically induced
  • Colonic Neoplasms / prevention & control*
  • Diet
  • Drug Evaluation, Preclinical
  • Food Analysis
  • Hesperidin / pharmacology*
  • Hesperidin / therapeutic use
  • Intestinal Mucosa / drug effects*
  • Intestinal Mucosa / pathology
  • Male
  • Molecular Structure
  • Quinolines / toxicity
  • Rats
  • Rats, Inbred F344
  • Tea / chemistry
  • Wine / analysis

Substances

  • Anticarcinogenic Agents
  • Carcinogens
  • Quinolines
  • Tea
  • 2-amino-3-methylimidazo(4,5-f)quinoline
  • Catechin
  • Hesperidin